US EditionUCL researchers launch congenital muscular dystrophy research programme
Summary by pharmatimes.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
UCL Researchers Launch Groundbreaking Congenital Muscular Dystrophy Research Program
University College London (UCL) researchers have initiated a pioneering research program to develop potential treatments for congenital muscular dystrophy (CMD) following a £1 million grant from LifeArc and Muscular Dystrophy UK. CMD, a group of inherited muscle diseases manifesting at birth or early infancy, presents with symptoms such as muscle weakness and joint tightness. With limited treatment options available, UCL’s research encompasses t…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
